Early Intra-aortic Balloon Pump Use After Venoarterial Extracorporeal Membrane Oxygenation

NCT ID: NCT06872021

Last Updated: 2025-11-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

358 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-01

Study Completion Date

2028-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this multicenter, randomized trial is to compare early early left ventricular unloading by Intra-aortic Balloon Pump (IABP) versus conventional approach in patients with cardiogenic shock (CS) undergoing venoarterial extracorporeal membrane oxygenation (VA-ECMO). The main question it aims to answer is :

• If left ventricular unloading by IABP as compared with the conventional approach will improve the outcomes in patients undergoing VA-ECMO.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The role of IABP combined with VA-ECMO in patients with CS remains unclear. Therefore, investigators will conduct a prospective randomized clinical trial to explore the effect of early IABP use for LV unloading after VA-ECMO on outcomes in patients with CS. Investigators will randomly assign 358 patients receiving peripheral VA-ECMO to the ECMO+IABP group (n=179) or the ECMO group (n=179). The primary end point was the 30-day mortality.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ECMO

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ECMO+IABP group

Patients receive IABP for left ventricular unloading within 6 hours after VA-ECMO initiation.

Group Type EXPERIMENTAL

Early IABP use

Intervention Type OTHER

Patients receive IABP for left ventricular unloading within 6 hours after VA-ECMO initiation.

ECMO group

Patients do not receive mechanical unloading within 6 hours after VA-ECMO initiation.

Group Type ACTIVE_COMPARATOR

Conventional approach

Intervention Type OTHER

Patients do not receive mechanical unloading within 6 hours after VA-ECMO initiation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Early IABP use

Patients receive IABP for left ventricular unloading within 6 hours after VA-ECMO initiation.

Intervention Type OTHER

Conventional approach

Patients do not receive mechanical unloading within 6 hours after VA-ECMO initiation.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age of ≥18
2. Cardiogenic shock(defined as a systolic blood pressure of less than 90 mm Hg for more than 30 minutes or the initiation of catecholamines to maintain a systolic pressure of more than 90 mm Hg, an arterial lactate level of more than 3 mmol per liter, and signs of impaired organ perfusion)
3. Successful implantation of VA-ECMO
4. Informed consent

Exclusion Criteria

1. Presence of moderate to severe aortic insufficiency or aortic dissection
2. Severe peripheral vascular disease
3. Post-cardiotomy cardiogenic shock(non-CABG procedure) or bridging to cardiac procedure.
4. VA-ECMO for definite non-cardiac causes
5. Extracorporeal cardiopulmonary resuscitation
6. Implantation of IABP or IMPELLA before VA-ECMO
7. Severe bleeding
8. Terminal malignancy
9. Irreversible neurologic injury
10. Pregnancy or lactation
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beijing Anzhen Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Xiaotong Hou

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Xiaotong Hou, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Beijing Anzhen Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Beijing Anzhen Hospital

Beijing, Beijing Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Xiaotong Hou, MD, PhD

Role: CONTACT

010-64456631

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Liangshan Wang, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KS2025197

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Physiology of Unloading VA ECMO Trial
NCT06336655 RECRUITING PHASE2
The Echodynamic Approach
NCT06859047 RECRUITING